There were 1,799 press releases posted in the last 24 hours and 253,125 in the last 365 days.

Global Enzyme Inhibitor Market Size And Market Growth Opportunities

Enzyme Inhibitor Market Report 2022: Market Size, Trends, And Forecast To 2026

Enzyme Inhibitor Global Market Report 2022: Market Size, Trends, And Forecast To 2026

The Business Research Company’s Enzyme Inhibitor Global Market Report 2022: Market Size, Trends, And Forecast To 2026

LONDON, GREATER LONDON, UK, August 12, 2022 / -- According to ‘Enzyme Inhibitor Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the enzyme inhibitor market size is expected to grow to $185.58 billion in 2026 at a CAGR of 1.8%. The rise in the incidence of diseases including cancer is expected to propel the enzyme inhibitor industry growth going forward.

Want to learn more on the enzyme inhibitor market growth? Request for a Sample now.

The enzyme inhibitor market consists of sales of enzyme inhibitors by entities (organizations, sole traders, and partnerships) that are used to treat Gaucher disease and also used as a tool for studying enzymes. Enzyme inhibitors are chemicals that attach to enzymes and prevent them from working. They attach to enzyme active sites and reduce enzyme compatibility with substrates, preventing the formation of enzyme-substrate complexes that result in reducing the reaction's catalysis and preventing the creation of products. Enzymes help to speed up chemical reactions in the body and take part in many cell functions, including cell signaling, growth, and division.

Global Enzyme Inhibitor Market Trends
Strategic partnerships and collaborations have emerged as one of the key enzyme inhibitor market trends gaining popularity. Major companies operating in enzyme inhibitors are focused on strategic partnerships to meet customer demand. For instance, in April 2021, Artios Pharma Limited, a UK-based DNA damage response company that also provides enzyme inhibitors, collaborated with Novartis International AG, a Switzerland-based pharmaceutical corporation, to uncover and verify new generation DDR (DNA Damage Response) targets to advance Novartis' Radioligand Therapies (RLT). This partnership with Novartis will be utilized to find and validate next-generation DDR targets to improve Novartis' radioligand therapies. Furthermore, in March 2020, Bayer AG, a Germany-based pharmaceutical and life sciences company, collaborated with Curadev, an Indian-based pharmaceutical company that provides enzyme inhibitors, to discover new drug candidates to provide treatment for lung diseases, cardiovascular diseases, and other inflammatory diseases.

Global Enzyme Inhibitor Market Segments
The global enzyme inhibitor market is segmented:
By Type: Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Statins, Others
By Disease Indication: Chronic Obstructive Pulmonary Disorders, Cardiovascular Disease, Gastrointestinal Disorders, Arthritis, Inflammatory Diseases, Others
By Application: Chemotherapy, Antibiotics, Pesticides, Cardiovascular Treatments, Others
By End-User: Pharmaceutical, Biotechnology, Food and Beverage, Others
By Geography: The global enzyme inhibitor market analysis report is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.

Read more on the global enzyme inhibitor market report here

Enzyme Inhibitor Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides enzyme inhibitor global market overviews, analyzes and forecasts market size and growth for the enzyme inhibitor market, enzyme inhibitor global market share, enzyme inhibitor global market segments and geographies, enzyme inhibitor global market players, enzyme inhibitor market leading competitor revenues, profiles and market shares. The enzyme inhibitor market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.

TBRC’s Enzyme Inhibitor Global Market Report 2022 includes information on the following:

Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: Abbott Laboratories, Amgen Inc, AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche AG, Pfizer Inc, Ranbaxy Laboratories, Takeda Pharmaceutical Company, Merck & Co. Inc, Eli Lilly and Company, Bristol Myers Squibb, Cipla USA Inc., AbbVie, Teva Pharmaceutical Industries Ltd, and Janssen Pharmaceuticals.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

And so much more.

Looking for something else? Here is a list of similar reports by The Business Research Company:

Enzymes Global Market Report 2022

Specialty Enzymes Global Market Report 2022

Protein Inhibitors Global Market Report 2022

About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Market Research Products, Services, Solutions For Your Business - TBRC